From: A cluster-randomized trial to reduce caesarean delivery rates in Quebec: cost-effectiveness analysis
Cost component | BMLM (crude) | BMLM (adjusted) | ||||||
---|---|---|---|---|---|---|---|---|
Coef. (ß) ($) | Std. Err. ($) | 95% CI ($) | P value | Coef. (ß) ($) | Std. Err. ($) | 95% CI ($) | P valuec | |
All participants (N = 105,351 patients; 32 hospitals) | ||||||||
Delivery (caesarean or vaginal)d | −8.3 | 8.2 | (−24.4 to 7.7) | 0.310 | −6.2 | 7.7 | (−21.3 to 9.0) | 0.424 |
Maternal complicationse | 19.9 | 30.0 | (−38.9 to 78.8) | 0.507 | 16.3 | 29.9 | (−42.3 to 74.8) | 0.586 |
Neonatal complicationsf | −196 | 33.8 | (−262 to −130) | <0.001 | −190 | 33.3 | (−255 to −125) | <0.001 |
Low-risk group (N = 49,281 patients; 32 hospitals) | ||||||||
Delivery (caesarean or vaginal)d | −17.2 | 9.4 | (−35.7 to 1.3) | 0.069 | −22.0 | 9.0 | (−39.5 to −4.5) | 0.014 |
Maternal complicationse | 22.0 | 38.4 | (−53.2 to 97.2) | 0.566 | 14.7 | 38.1 | (−59.9 to 89.3) | 0.700 |
Neonatal complicationsf | −215 | 42.0 | (−297 to −133) | <0.001 | −219 | 41.8 | (−301 to −137) | <0.001 |
High-risk group (N = 56,070 patients; 32 hospitals) | ||||||||
Delivery (caesarean or vaginal)d | 17.6 | 12.2 | (−6.3 to 41.6) | 0.149 | 14.8 | 12.2 | (−9.0 to 38.7) | 0.223 |
Maternal complicationse | 17.6 | 45.3 | (−71.2 to 106) | 0.698 | 14.2 | 45.1 | (−74.3 to 103) | 0.753 |
Neonatal complicationsf | −136 | 51.2 | (−237 to −36.0) | 0.008 | −126 | 50.0 | (−224 to −27.6) | 0.012 |